For research use only. Not for therapeutic Use.
Folinic acid-d4 calcium hydrate, a premium pharmaceutical research compound designed for advanced metabolic and oncology studies. As a deuterated analog of Folinic acid, it offers enhanced stability and improved pharmacokinetic properties. Folinic acid-d4 calcium hydrate is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for cancer and metabolic disorders. Trusted by leading laboratories, Folinic acid-d4 calcium hydrate is your go-to solution for cutting-edge metabolic and cancer research. Unlock new possibilities in treatment with Folinic acid-d4 calcium hydrate, where innovation meets reliability.
| Catalog Number | S000232 |
| Molecular Formula | C20H17D4CaN7O7.xH2O |
| Purity | ≥95% |
| SMILES | O=C([O-])CC[C@@H](C([O-])=O)NC(C1=CC=C(NC([2H])([2H])C2([2H])N(C=O)C3=C(NC(N)=NC3=O)NC2[2H])C=C1)=O.[F,Cl,Br,I].O.[Ca+2] |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Keshava, C., et al., Inhibition of methotrexate-induced chromosomal damage by folinic acid in V79 cells. Mutat Res, 1998. 397(2): p. 221-8. [3]. Iqbal MP, et al. Effect of methotrexate and folinic acid on skeletal growth in mice. Acta Paediatr. 2003 Dec;92(12):1438-44. |
